Matches in Wikidata for { <http://www.wikidata.org/entity/Q93086704> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q93086704 description "article scientifique publié en 2019" @default.
- Q93086704 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93086704 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93086704 description "scientific article published on 27 June 2019" @default.
- Q93086704 description "wetenschappelijk artikel" @default.
- Q93086704 description "наукова стаття, опублікована 27 червня 2019" @default.
- Q93086704 name "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 name "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 type Item @default.
- Q93086704 label "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 label "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 prefLabel "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 prefLabel "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 P1433 Q93086704-0BE3D268-EC6E-4030-92E8-98BF83F705CC @default.
- Q93086704 P1476 Q93086704-DE2D803C-5A00-4DB3-9E88-EBCF2426AA8A @default.
- Q93086704 P2093 Q93086704-BDEA07ED-2AA7-4409-A2B3-725B41A69FC6 @default.
- Q93086704 P2093 Q93086704-CC28DC7B-1D80-4FFC-8C55-01C4DCF789C5 @default.
- Q93086704 P2093 Q93086704-D1E29FC3-980D-478E-B50F-1721471DF307 @default.
- Q93086704 P2093 Q93086704-EA15A40D-4C7E-4D57-B42C-4B14484FC2C4 @default.
- Q93086704 P304 Q93086704-43957157-20AE-4F4C-B215-68EA7928DFD5 @default.
- Q93086704 P31 Q93086704-34EF4823-9D9B-4B10-99D3-6752E37939C2 @default.
- Q93086704 P356 Q93086704-480638DB-A3EB-4D7D-BDC5-B2246894CA12 @default.
- Q93086704 P433 Q93086704-98E609E1-263E-4F67-B38B-197439998FF9 @default.
- Q93086704 P478 Q93086704-CB89CBEA-AFE3-463D-9766-FE14A8F76546 @default.
- Q93086704 P50 Q93086704-C433B4CF-6C5E-4925-A7DA-988986F0040F @default.
- Q93086704 P577 Q93086704-4DA55BEE-E478-4EE2-AB2F-527EFA49B3AB @default.
- Q93086704 P698 Q93086704-B1D92D28-34F7-4C7D-9FA4-67D32D2044C1 @default.
- Q93086704 P921 Q93086704-335AF391-9965-43CC-9F54-815D54131868 @default.
- Q93086704 P921 Q93086704-68E4DFAD-F7ED-472F-9A2F-F4118E43A8E6 @default.
- Q93086704 P921 Q93086704-7AAB91A4-9DC8-4153-A98C-111039F5206B @default.
- Q93086704 P932 Q93086704-E9E42C0F-B2EC-4EBF-9581-640437DCAAB6 @default.
- Q93086704 P356 CJN.14751218 @default.
- Q93086704 P698 31248950 @default.
- Q93086704 P1433 Q15757929 @default.
- Q93086704 P1476 "Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial" @default.
- Q93086704 P2093 "Kenichi Shikata" @default.
- Q93086704 P2093 "Masaomi Nangaku" @default.
- Q93086704 P2093 "Tomoko Sawanobori" @default.
- Q93086704 P2093 "Yasuyuki Okuda" @default.
- Q93086704 P304 "1161-1172" @default.
- Q93086704 P31 Q13442814 @default.
- Q93086704 P356 "10.2215/CJN.14751218" @default.
- Q93086704 P433 "8" @default.
- Q93086704 P478 "14" @default.
- Q93086704 P50 Q30932255 @default.
- Q93086704 P577 "2019-06-27T00:00:00Z" @default.
- Q93086704 P698 "31248950" @default.
- Q93086704 P921 Q269829 @default.
- Q93086704 P921 Q3025883 @default.
- Q93086704 P921 Q42824440 @default.
- Q93086704 P932 "6682830" @default.